Cannabinoids and glaucoma.

Cannabinoids and glaucoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cannabinoids and glaucoma. Abstract Text:

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Cannabinoids and glaucoma. Publishing Authors By Initials

For similar complex mixtures: biological products: plant preparations: plant extracts research abstracts see: complex mixtures: biological products: plant preparations: plant extracts research

PUBMED ID PMID:

MEDLINE DATE:

Cannabinoids and glaucoma. Journal Published:

PUBLICATION TYPE: Review

Journal: The British journal of ophthalmology

VOLUME: 88

Page Numbers: 708-13

Journal Abbreviation: Br J Ophthalmol

ISSN: 0007-1161

DAY: 28

MONTH: May

YEAR: 2004

Cannabinoids and glaucoma. Information

Number of References: 71

LANGUAGE: eng

NlmUniqueID: 421041

Cannabinoids and glaucoma. Keywords Mesh Terms:

KEYWORDS: Plant Extracts

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Cannabinoids and glaucoma. Information

Substance Name: Plant Extracts

Registry Number: 0

Grant and Affiliation Information for Cannabinoids and glaucoma.

AFFILIATION: Department of Ophthalmology, Aberdeen Royal Infirmary, University of Aberdeen, UK.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Ophthalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cannabinoids and glaucoma Related Publications

• A review of glaucoma treatment in Scotland 1994-2004.
• Allo-limbal transplantation in patients with limbal stem cell deficiency.
• Amniotic membrane transplantation.
• Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency.
• Cannabinoids and glaucoma.
• Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment.
• Increasing the size of a small peripheral iridotomy widens the anterior chamber angle: an ultrasound biomicroscopy study.
• Laser peripheral iridoplasty for angle-closure.
• Lower corneal hysteresis in glaucoma patients with acquired pit of the optic nerve (APON).
• Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
• The quality of reporting of diagnostic accuracy studies in glaucoma using scanning laser polarimetry.